Program letters clarify Ryan White HIV/AIDS Program (RWHAP) policy notices and initiatives. Policy Notices explain how to carry out RWHAP legislative requirements.
2025
- Joint Letter from HRSA and SAMHSA on Improving Care and Treatment for People with HIV and SUD (PDF - 173 KB) - January 17, 2025
2024
- Ryan White Program 2030 - December 20, 2024 (PDF - 294 KB)
- Older Adults, Long-term Survivors, and Life-term Survivors in the Ryan White HIV/AIDS Program (PDF - 91 KB) - August 16, 2024
- Housing Security Deposits in the Ryan White HIV/AIDS Program (PDF - 81 KB) - June 26, 2024
- Expungement Services for People with HIV Who Have Had Legal System Involvement (PDF - 64 KB) - June 6, 2024
- Change Healthcare Cyberattack Letter to Health Care Leaders (PDF - 45 KB) - March 11, 2024
2023
- Ryan White HIV/AIDS Program Planning Council and Planning Body Requirements and Expectations Letter (PDF - 35 KB) - August 29, 2023
- RWHAP Parts A and B Annual Site Visit Exemption (PDF) - August 23, 2023
- Syphilis and Congenital Syphilis in Indian Country (PDF - 196 KB) - July 6, 2023
- Ryan White HIV/AIDS Program AIDS Drug Assistance Program Recipients and Buprenorphine and Naloxone (PDF - 170 KB) - May 11, 2023
- HRSA, CDC, and HUD Housing Status and HIV Outbreaks Letter (PDF - 151 KB) - April 12, 2023
- First Medication in New Capsid Inhibitor Antiretroviral Class (PDF - 30 KB) - April 3, 2023
- Medicaid Continuous Enrollment Unwinding for the Ryan White HIV/AIDS Program (PDF - 182 KB) - March 23, 2023
- Ryan White HIV/AIDS Program and FY 2023 COVID-19 Programmatic Waivers (PDF - 107 KB) - March 2, 2023
- Supporting Community Engagement in the Ryan White HIV/AIDS Program (PDF - 39 KB) - February 28, 2023
2022
- Ryan White HIV/AIDS Program Part A Guidance for Planning Councils and Planning Bodies on Supporting People with Lived Experience (PDF - 102 KB) - December 6, 2022
- FY 2022 Penalties Waivers for Ryan White HIV/AIDS Program Recipients (PDF - 71 KB) - April 26, 2022
- Ryan White HIV/AIDS Program Part A and Part B Recipients Annual Site Visit Letter (PDF - 76 KB) - March 30, 2022
2021
- Gender-Affirming Care in the Ryan White HIV/AIDS Program (PDF - 175 KB) - December 16, 2021 and updated with disclaimer February 14, 2025.**
** Per a court order, HHS is required to restore this website as of 11:59 p.m., February 14, 2025. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from the immutable biological reality that there are two sexes, male and female. The Trump Administration rejects gender ideology and condemns the harms it causes to children, by promoting their chemical and surgical mutilation, and to women, by depriving them of their dignity, safety, well-being, and opportunities. This page does not reflect biological reality and therefore the Administration and this Department rejects it. - Clarification on Transitioning Clients from Ending the HIV Epidemic Funding to Ryan White HIV/AIDS Program and AIDS Drug Assistance Program Funding (PDF) - March 22, 2021
- Waiving Penalties and Administrative Requirements for Ryan White HIV/AIDS Program Recipients (PDF - 241 KB) - February 23, 2021
- Ryan White HIV/AIDS Program and COVID-19 Programmatic Waivers (PDF - 147 KB) - January 27, 2021
- COVID-19 Vaccines and the Ryan White HIV/AIDS Program (PDF - 137 KB) - January 15, 2021
2020
- Ryan White HIV/AIDS Program and COVID-19 Letter (PDF - 41 KB) - September 10, 2020
- Integrated HIV Prevention and Care Plan Guidance Postponement Guidance for Ryan White HIV/AIDS Program Parts A and B Recipients (PDF - 216 KB) - June 17, 2020
2019
- Long-acting Antiretroviral (ARV) Medication Guidance and Ryan White HIV/AIDS Program (PDF - 298 KB) - December 4, 2019
- Rapid Eligibility Determinations and Ryan White HIV/AIDS Program (PDF - 170 KB) - May 2, 2019
- RWHAP Parts A and B Annual Site Visit Exemption (PDF - 280 KB) - April 30, 2019
2018
- First Medication in New Antiretroviral Drug Class (PDF - 201 KB) - October 26, 2018
- Ryan White HIV/AIDS Program and Incorporating Messages on the Impact of Viral Suppression (PDF - 389 KB) - October 19, 2018
2017
- Retirement of 11-06 AIDS Drug Assistance Program: Use of Funds, Eligibility and Formulary Parity, Administration, Quality Assurance and Cost-Savings (PDF - 215 KB) - December 12, 2017
- Integrating and Using the Housing Opportunities for Persons with AIDS and Ryan White HIV/AIDS Program Data Sets (PDF - 417 KB) - August 29, 2017
2016
- Using Ryan White HIV/AIDS Program Funds to Support Standalone Dental Insurance (PDF - 199 KB) - December 5, 2016
- Using Ryan White HIV/AIDS Program Funds to Support Housing Services (PDF - 337 KB) - August 18, 2016
2015
- Ryan White HIV/AIDS Program Service Categories Crosswalk with the HIV Care Continuum (PDF - 149 KB) - June 11, 2015
- HCV Medications (PDF - 77 KB) February 13, 2015
2014
- Clarification of CD4 Reporting (PDF - 144 KB) - December 2, 2014
- RWHAP Comprehensive Plans/SCSN and CDC Jurisdictional Plan Submissions (PDF - 27 KB) - February 24, 2014
- AIDS Drug Assistance Programs and the 340B Drug Pricing Program (PDF - 238 KB) - January 31, 2014
2013 and Older
- Transitional Grant Areas and Planning Councils Moving Forward (PDF - 308 KB) - December 4, 2013
- Static MSA Boundaries for Part A EMAs and TGAs Letter (PDF - 441 KB) - November 7, 2013
- Local Pharmaceutical Assistance Programs (LPAP) Clarification (PDF - 461 KB) - August 29, 2013
- HRSA CDC Letter in Support of Integrated HIV Planning (PDF - 32 KB) - May 22, 2013
- Coordination between Medicaid and Ryan White HIV/AIDS Programs (PDF - 113 KB) - May 1, 2013
- ACA Plans Offered Through Marketplace Known as QHPs and ECPs (PDF - 291 KB) - March 27, 2013
- HRSA CDC HIV Testing Letter (PDF - 432 KB) - February 25, 2013
- Use of Funds and Activities for Program Development (PDF - 27 KB) - April 26, 2012
- ADAP/TrOOP (PDF - 481 KB) - November 23, 2010
- ADAP/340b (PDF - 298 KB) - April 29, 2005
- Medicaid Coordination (PDF - 38 KB) - August 10, 2000
*Note: If you use assistive technology, you may not be able to access information in this file. For help, please call 301-443-0999.
Date Last Reviewed: